Ridge Diagnostics, Inc. to Present on Blood Tests for Depression at OneMedForum

Ridge Diagnostics, Inc. to Present on Blood Tests for Depression at OneMedForum

San Diego, CA January 8, 2013 – Ridge Diagnostics, Inc., a neurodiagnostic company, announced that Lonna J. Williams, CEO, will speak at the 6th Annual OneMedForum San Francisco 2013, to be held at The Sir Francis Drake Hotel on January 8, 2013 at 2:10pm.

Ms. Williams, a clinical diagnostics industry veteran, will discuss the innovative Ridge technology for diagnosing Major Depressive Disorder from blood samples, and the expansion of the company’s clinical program for a test to predict antidepressant drug response.

For the first time, blood tests provide clinicians and patients with objective, biologically-based diagnostic information to manage and treat depression. The blood test results are intended to augment the current tools used for neuropsychiatric diagnosis, therapy selection and patient management.

Ridge Diagnostics, Inc. Ridge Diagnostics is a neurodiagnostic company developing and marketing blood-based tests to diagnose and monitor neuropsychiatric disorders. Ridge has commercialized the first-in-class, proprietary blood test for the diagnosis and treatment monitoring of Major Depressive Disorder (MDD). The portfolio of neurodiagnostic blood tests are based on a proprietary Human Biomarker Library and Hyper-Mapping technology. The testing services are provided by the Ridge owned CLIA laboratory. The company is located in San Diego, CA and Research Triangle Park, NC.  www.ridgex.com

 

Contacts:

Ridge Diagnostics: Lonna J Williams, CEO

800-578-7818 ex 101

lwilliams@ridgedx.com

www.onemedplace.com/forum/

 

Ridge Diagnostics, Inc. to Present on Blood Tests for Depression at OneMedForum

 

San Diego, CA January 8, 2013 – Ridge Diagnostics, Inc., a neurodiagnostic company,

announced that Lonna J. Williams, CEO, will speak at the 6th Annual OneMedForum San

Francisco 2013, to be held at The Sir Francis Drake Hotel on January 8, 2013 at 2:10pm.

Ms. Williams, a clinical diagnostics industry veteran, will discuss the innovative Ridge

technology for diagnosing Major Depressive Disorder from blood samples, and the expansion of

the company’s clinical program for a test to predict antidepressant drug response.

For the first time, blood tests provide clinicians and patients with objective, biologically-based

diagnostic information to manage and treat depression. The blood test results are intended to

augment the current tools used for neuropsychiatric diagnosis, therapy selection and patient

management.

Ridge Diagnostics, Inc. Ridge Diagnostics is a neurodiagnostic company developing and

marketing blood-based tests to diagnose and monitor neuropsychiatric disorders. Ridge has

commercialized the first-in-class, proprietary blood test for the diagnosis and treatment

monitoring of Major Depressive Disorder (MDD). The portfolio of neurodiagnostic blood tests

are based on a proprietary Human Biomarker Library and Hyper-Mapping technology. The

testing services are provided by the Ridge owned CLIA laboratory. The company is located in

San Diego, CA and Research Triangle Park, NC.  www.ridgex.com

 

Contacts:

Ridge Diagnostics: Lonna J Williams, CEO

800-578-7818 ex 101

lwilliams@ridgedx.com

www.onemedplace.com/forum/

The comments are closed.